Clinical Trial Update: Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating LUM001 with ursodeoxycholic acid in primary biliary cirrhosis has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Drugs mentioned

• LUM001
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Mirum Pharmaceuticals, Inc. | Conditions: PBC, Primary Biliary Cirrhosis | Phase 2 | Status: COMPLETED | Results posted: 2016-07-06